HC Williams
John Wiley & Sons
3e druk, 2014
9781118357675
Evidence–Based Dermatology 3e
Specificaties
Gebonden, 680 blz.
|
Engels
John Wiley & Sons |
3e druk, 2014
ISBN13: 9781118357675
Rubricering
Onderdeel van serie
Evidence–Based Medicine
Verwachte levertijd ongeveer 16 werkdagen
Samenvatting
Be sure your skin–care treatments have strong evidential support
Evidence–based Dermatology, Third Edition takes a unique approach to clinical dermatology by emphasising use of only the highest quality available evidence when treating people with skin diseases.
Beginning with a toolbox introduction to the practice of evidence–based dermatology, it then covers the application of evidence for dermatological treatments across a wide range of ailments, including:
Common inflammatory skin diseases
Skin cancer, moles and actinic keratoses
Infective skin disease, exanthems and infestations
Disorders of pigmentation
In addition, many of the rarer skin disorders are also included so as to provide comprehensive coverage of the topic.
World–leading experts in dermatology follow a clinical approach for each disease, and as well as providing their expert guidance on the description and diagnosis of dermatologic disorders, they also discuss common dilemmas that clinicians face when considering the best approach to patient management. Key Points accompany each chapter to provide a quick review of the most important points.
Clinically oriented and practically focused, Evidence–based Dermatology ensures that your treatments are entirely patient–focused and fully supported by the very latest medical evidence.
Specificaties
ISBN13:9781118357675
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:680
Uitgever:John Wiley & Sons
Druk:3
Serie:Evidence–Based Medicine
Inhoudsopgave
<p>Contributors, viii</p>
<p>Foreword, xii</p>
<p>Preface, xiv</p>
<p>About the companion website, xv</p>
<p>PART I: The concept of evidence–based dermatology<br /> Andrew Herxheimer, editor</p>
<p>1 The field and its boundaries, 3<br /> Luigi Naldi</p>
<p>2 The rationale for evidence–based dermatology, 7<br /> Hywel C. Williams and Michael Bigby</p>
<p>3 The role of patient and public involvement in evidence–based dermatology, 12<br /> Carron Layfield, Amanda Roberts, Jason Simons, Colette O′Sullivan, Anjna Rani, and Kim Thomas</p>
<p>4 The Cochrane Skin Group, 17<br /> Finola Delamere, Liz Doney, Laura Prescott, and Shirley Manknell</p>
<p>PART II: The critical appraisal toolbox<br /> Michael Bigby, editor</p>
<p>5 Formulating well–built clinical questions, 25<br /> Michael Bigby and Berthold Rzany</p>
<p>6 Finding the best evidence, 27<br /> Michael Bigby and Rosamaria Corona</p>
<p>7 The hierarchy of evidence, 30<br /> Michael Bigby</p>
<p>8 Appraising systematic reviews and meta–analyses, 33<br /> Michael Bigby and Hywel C. Williams</p>
<p>9 How to critically appraise a randomized controlled trial, 39<br /> Hywel C. Williams</p>
<p>10 Assessing and explaining the evidence on harms of medical interventions, 46<br /> Luigi Naldi</p>
<p>11 How to evaluate diagnostic tests, 50<br /> Joerg Albrecht and Michael Bigby</p>
<p>12 What makes a good case series?, 54<br /> Joerg Albrecht and Michael Bigby</p>
<p>13 What makes a good prevalence survey?, 58<br /> Hywel C. Williams</p>
<p>14 Critical appraisal of pharmacoeconomic studies, 62<br /> Rajini K. Murthy, Laura K. DeLong, and Suephy C. Chen</p>
<p>15 Comparative effectiveness research: what it is and how to assess its quality, 66<br /> Junko Takeshita and Joel M. Gelfand</p>
<p>16 Outcome measures, 71<br /> Alain Dupuy, Emilie Sbidian, and Sylvie Bastuji–Garin</p>
<p>17 Where does qualitative research fit into evidence–based dermatology?, 75<br /> Ray Jobling and Luigi Naldi</p>
<p>18 Applying the evidence back to the patient, 79<br /> Hywel C. Williams</p>
<p>PART III: The evidence</p>
<p>SECTION 1: Common inflammatory skin diseases<br /> Luigi Naldi, editor</p>
<p>19 Acne vulgaris, 87<br /> Michael Romano and Robert P. Dellavalle</p>
<p>20 Papulopustular rosacea, 106<br /> Alfredo Rebora and Francesco Drago</p>
<p>21 Perioral dermatitis, 112<br /> Vincenzo Bettoli, Stefania Zauli, and Annarosa Virgili</p>
<p>22 Hand eczema, 117<br /> Wietske A. Christoffers, Marie–Louise Anna Schuttelaar, and Pieter–Jan Coenraads</p>
<p>23 The primary prevention of atopic dermatitis, 127<br /> Joanne R. Chalmers, Sam F. Bremmer, and Eric L. Simpson</p>
<p>24 Atopic eczema, 136<br /> Kim Thomas, Carolyn Charman, Helen Nankervis, Jane Ravenscroft, and Hywel C. Williams</p>
<p>25 Seborrheic dermatitis, 169<br /> Mauro Picardo and Norma Cameli</p>
<p>26 Treatment of psoriasis, 175<br /> Alexander Nast, Phyllis Spuls, and Tamar Nijsten</p>
<p>27 Lichen planus, 200<br /> Laurence Le Cleach and Olivier Chosidow</p>
<p>28 Acute urticaria, 206<br /> Torsten Schafer</p>
<p>29 Chronic urticaria, 210<br /> Karsten Weller and Marcus Maurer</p>
<p>SECTION 2: Skin cancer, moles, and actinic keratoses<br /> Robert Dellavalle, editor</p>
<p>30 Primary prevention of skin cancer, 223<br /> Monika Janda and Adele C. Green</p>
<p>31 Treatment of cutaneous melanoma, 231<br /> Mary Ann N. Johnson and April W. Armstrong</p>
<p>32 Treatment of squamous cell carcinoma, 241<br /> Louise Lansbury, William Perkins, and Fiona Bath–Hextall</p>
<p>33 Basal cell carcinoma, 250<br /> Fiona Bath–Hextall and William Perkins</p>
<p>34 Primary cutaneous T–cell lymphoma, 264<br /> Fiona Child and Sean Whittaker</p>
<p>35 Actinic keratosis and Bowen′s disease, 283<br /> Sasha N. Jenkins, Maren Speck, and Suephy C. Chen</p>
<p>36 Kaposi sarcoma, 303<br /> Whitney A. High</p>
<p>37 Melanocytic nevi, 313<br /> Varun Shahi and Jerry D. Brewer</p>
<p>SECTION 3: Infective skin diseases, exanthems, and infestations<br /> Masutaka Furue and Yuping Ran, editors</p>
<p>38 Local treatments for cutaneous warts, 320<br /> Juping Chen and Yan Wu</p>
<p>39 Molluscum contagiosum, 329<br /> Minh L. Lam</p>
<p>40 Impetigo, 337<br /> Sander Koning, Renske van der Sande, Lisette W.A. van Suijlekom–Smit, and Johannes C. van der Wouden</p>
<p>41 Athlete′s foot, 341<br /> Inajara Rotta, Michel F. Otuki, and Cassyano J. Correr</p>
<p>42 Pityriasis versicolor, 345<br /> Nancy Habib and Michael Bigby</p>
<p>43 Onychomycosis, 349<br /> Aditya K. Gupta, Elizabeth A. Cooper, Maryse Paquet, and Fiona Simpson</p>
<p>44 Tinea capitis, 364<br /> Urba Gonzalez</p>
<p>45 Deep fungal infections, 371<br /> Roderick J. Hay</p>
<p>46 Streptococcal cellulitis/erysipelas of the lower leg, 378<br /> Vinod E. Nambudiri and Michael Bigby</p>
<p>47 Exanthematic reactions, 388<br /> Sandra R. Knowles and Neil H. Shear</p>
<p>48 Herpes simplex, 396<br /> Vera Mahler</p>
<p>49 Leprosy, 407<br /> Saumya Panda</p>
<p>50 Cutaneous leishmaniasis, 421<br /> Urba Gonzalez, Armando Ruiz–Baques, and Jorge Alvar</p>
<p>51 Scabies, 432<br /> Ian F. Burgess</p>
<p>52 Head lice, 441<br /> Ian F. Burgess and Ciara S. Casey</p>
<p>53 Insect bites and stings, 451<br /> Belen Lardizabal Dofitas</p>
<p>SECTION 4: Disorders of pigmentation<br /> Hywel C. Williams, editor</p>
<p>54 Vitiligo, 464<br /> Juan Jorge Manriquez and Sergio M. Niklitschek</p>
<p>55 Melasma, 470<br /> Asad Salim, Ratna Rajaratnam, and Eva Soos Domanne</p>
<p>SECTION 5: Common ailments with significant cosmetic impact<br /> Berthold Rzany, editor</p>
<p>56 Male and female androgenetic alopecia, 486<br /> Hans Wolff and Kathrin Giehl</p>
<p>57 Alopecia areata, 490<br /> Rod Sinclair</p>
<p>58 Evidence–based treatment of hirsutism, 498<br /> Ulrike Blume–Peytavi and Natalie Garcia–Bartels</p>
<p>59 Focal hyperhidrosis, 504<br /> Kave Shams and Berthold Rzany</p>
<p>60 Dermal fillers, 512<br /> Stephanie Ogden and Tamara Griffiths</p>
<p>61 Reducing mimic wrinkles and folds with botulinum toxin A, 516<br /> Berthold Rzany</p>
<p>SECTION 6: Other important skin disorders<br /> Michael Bigby, editor</p>
<p>62 Cutaneous lupus erythematosus, 523<br /> Susan Jessop and David Whitelaw</p>
<p>63 Dermatomyositis, 531<br /> Ruth Ann Vleugels, David F. Fiorentino, and Jeffrey P. Callen</p>
<p>64 Acquired subepidermal bullous diseases, 545<br /> Gudula Kirtschig, Vanessa Venning, Nonhlanhla P. Khumalo, and Fenella Wojnarowska</p>
<p>65 Pemphigus, 552<br /> Linda K. Martin, Brian R. Sperber, Dedee F. Murrell, and Victoria P. Werth</p>
<p>66 Cutaneous sarcoidosis, 561<br /> Misha Rosenbach and Joseph C. English III</p>
<p>67 Erythema multiforme, 575<br /> Pierre–Dominique Ghislain and Jean–Claude Roujeau</p>
<p>68 Stevens Johnson syndrome and toxic epidermal necrolysis, 578<br /> Jean–Claude Roujeau, Pierre–Dominique Ghislain, and Laurence Valleyrie–Allanore</p>
<p>69 Polymorphic light eruption, 586<br /> Robert S. Dawe</p>
<p>70 Infantile hemangiomas, 590<br /> Hossain Shahidullah</p>
<p>71 Pruritus, 595<br /> Elke Weisshaar and Gil Yosipovitch</p>
<p>72 Vulval lichen sclerosus, erosive lichen planus, and vulvodynia, 615<br /> Rosalind C. Simpson, Ruth Murphy, and David Nunns</p>
<p>73 Venous ulcers, 624<br /> Jonathan Kantor, David J. Margolis, and Douglas J. Pugliese</p>
<p>74 Other skin diseases for which trials exist, 632<br /> Sinead Langan and Hywel C. Williams</p>
<p>PART IV: The future of evidence–based dermatology<br /> Luigi Naldi, editor</p>
<p>75 Where do we go from here?, 637<br /> Hywel C. Williams</p>
<p>Subject Index, 644</p>
<p>Foreword, xii</p>
<p>Preface, xiv</p>
<p>About the companion website, xv</p>
<p>PART I: The concept of evidence–based dermatology<br /> Andrew Herxheimer, editor</p>
<p>1 The field and its boundaries, 3<br /> Luigi Naldi</p>
<p>2 The rationale for evidence–based dermatology, 7<br /> Hywel C. Williams and Michael Bigby</p>
<p>3 The role of patient and public involvement in evidence–based dermatology, 12<br /> Carron Layfield, Amanda Roberts, Jason Simons, Colette O′Sullivan, Anjna Rani, and Kim Thomas</p>
<p>4 The Cochrane Skin Group, 17<br /> Finola Delamere, Liz Doney, Laura Prescott, and Shirley Manknell</p>
<p>PART II: The critical appraisal toolbox<br /> Michael Bigby, editor</p>
<p>5 Formulating well–built clinical questions, 25<br /> Michael Bigby and Berthold Rzany</p>
<p>6 Finding the best evidence, 27<br /> Michael Bigby and Rosamaria Corona</p>
<p>7 The hierarchy of evidence, 30<br /> Michael Bigby</p>
<p>8 Appraising systematic reviews and meta–analyses, 33<br /> Michael Bigby and Hywel C. Williams</p>
<p>9 How to critically appraise a randomized controlled trial, 39<br /> Hywel C. Williams</p>
<p>10 Assessing and explaining the evidence on harms of medical interventions, 46<br /> Luigi Naldi</p>
<p>11 How to evaluate diagnostic tests, 50<br /> Joerg Albrecht and Michael Bigby</p>
<p>12 What makes a good case series?, 54<br /> Joerg Albrecht and Michael Bigby</p>
<p>13 What makes a good prevalence survey?, 58<br /> Hywel C. Williams</p>
<p>14 Critical appraisal of pharmacoeconomic studies, 62<br /> Rajini K. Murthy, Laura K. DeLong, and Suephy C. Chen</p>
<p>15 Comparative effectiveness research: what it is and how to assess its quality, 66<br /> Junko Takeshita and Joel M. Gelfand</p>
<p>16 Outcome measures, 71<br /> Alain Dupuy, Emilie Sbidian, and Sylvie Bastuji–Garin</p>
<p>17 Where does qualitative research fit into evidence–based dermatology?, 75<br /> Ray Jobling and Luigi Naldi</p>
<p>18 Applying the evidence back to the patient, 79<br /> Hywel C. Williams</p>
<p>PART III: The evidence</p>
<p>SECTION 1: Common inflammatory skin diseases<br /> Luigi Naldi, editor</p>
<p>19 Acne vulgaris, 87<br /> Michael Romano and Robert P. Dellavalle</p>
<p>20 Papulopustular rosacea, 106<br /> Alfredo Rebora and Francesco Drago</p>
<p>21 Perioral dermatitis, 112<br /> Vincenzo Bettoli, Stefania Zauli, and Annarosa Virgili</p>
<p>22 Hand eczema, 117<br /> Wietske A. Christoffers, Marie–Louise Anna Schuttelaar, and Pieter–Jan Coenraads</p>
<p>23 The primary prevention of atopic dermatitis, 127<br /> Joanne R. Chalmers, Sam F. Bremmer, and Eric L. Simpson</p>
<p>24 Atopic eczema, 136<br /> Kim Thomas, Carolyn Charman, Helen Nankervis, Jane Ravenscroft, and Hywel C. Williams</p>
<p>25 Seborrheic dermatitis, 169<br /> Mauro Picardo and Norma Cameli</p>
<p>26 Treatment of psoriasis, 175<br /> Alexander Nast, Phyllis Spuls, and Tamar Nijsten</p>
<p>27 Lichen planus, 200<br /> Laurence Le Cleach and Olivier Chosidow</p>
<p>28 Acute urticaria, 206<br /> Torsten Schafer</p>
<p>29 Chronic urticaria, 210<br /> Karsten Weller and Marcus Maurer</p>
<p>SECTION 2: Skin cancer, moles, and actinic keratoses<br /> Robert Dellavalle, editor</p>
<p>30 Primary prevention of skin cancer, 223<br /> Monika Janda and Adele C. Green</p>
<p>31 Treatment of cutaneous melanoma, 231<br /> Mary Ann N. Johnson and April W. Armstrong</p>
<p>32 Treatment of squamous cell carcinoma, 241<br /> Louise Lansbury, William Perkins, and Fiona Bath–Hextall</p>
<p>33 Basal cell carcinoma, 250<br /> Fiona Bath–Hextall and William Perkins</p>
<p>34 Primary cutaneous T–cell lymphoma, 264<br /> Fiona Child and Sean Whittaker</p>
<p>35 Actinic keratosis and Bowen′s disease, 283<br /> Sasha N. Jenkins, Maren Speck, and Suephy C. Chen</p>
<p>36 Kaposi sarcoma, 303<br /> Whitney A. High</p>
<p>37 Melanocytic nevi, 313<br /> Varun Shahi and Jerry D. Brewer</p>
<p>SECTION 3: Infective skin diseases, exanthems, and infestations<br /> Masutaka Furue and Yuping Ran, editors</p>
<p>38 Local treatments for cutaneous warts, 320<br /> Juping Chen and Yan Wu</p>
<p>39 Molluscum contagiosum, 329<br /> Minh L. Lam</p>
<p>40 Impetigo, 337<br /> Sander Koning, Renske van der Sande, Lisette W.A. van Suijlekom–Smit, and Johannes C. van der Wouden</p>
<p>41 Athlete′s foot, 341<br /> Inajara Rotta, Michel F. Otuki, and Cassyano J. Correr</p>
<p>42 Pityriasis versicolor, 345<br /> Nancy Habib and Michael Bigby</p>
<p>43 Onychomycosis, 349<br /> Aditya K. Gupta, Elizabeth A. Cooper, Maryse Paquet, and Fiona Simpson</p>
<p>44 Tinea capitis, 364<br /> Urba Gonzalez</p>
<p>45 Deep fungal infections, 371<br /> Roderick J. Hay</p>
<p>46 Streptococcal cellulitis/erysipelas of the lower leg, 378<br /> Vinod E. Nambudiri and Michael Bigby</p>
<p>47 Exanthematic reactions, 388<br /> Sandra R. Knowles and Neil H. Shear</p>
<p>48 Herpes simplex, 396<br /> Vera Mahler</p>
<p>49 Leprosy, 407<br /> Saumya Panda</p>
<p>50 Cutaneous leishmaniasis, 421<br /> Urba Gonzalez, Armando Ruiz–Baques, and Jorge Alvar</p>
<p>51 Scabies, 432<br /> Ian F. Burgess</p>
<p>52 Head lice, 441<br /> Ian F. Burgess and Ciara S. Casey</p>
<p>53 Insect bites and stings, 451<br /> Belen Lardizabal Dofitas</p>
<p>SECTION 4: Disorders of pigmentation<br /> Hywel C. Williams, editor</p>
<p>54 Vitiligo, 464<br /> Juan Jorge Manriquez and Sergio M. Niklitschek</p>
<p>55 Melasma, 470<br /> Asad Salim, Ratna Rajaratnam, and Eva Soos Domanne</p>
<p>SECTION 5: Common ailments with significant cosmetic impact<br /> Berthold Rzany, editor</p>
<p>56 Male and female androgenetic alopecia, 486<br /> Hans Wolff and Kathrin Giehl</p>
<p>57 Alopecia areata, 490<br /> Rod Sinclair</p>
<p>58 Evidence–based treatment of hirsutism, 498<br /> Ulrike Blume–Peytavi and Natalie Garcia–Bartels</p>
<p>59 Focal hyperhidrosis, 504<br /> Kave Shams and Berthold Rzany</p>
<p>60 Dermal fillers, 512<br /> Stephanie Ogden and Tamara Griffiths</p>
<p>61 Reducing mimic wrinkles and folds with botulinum toxin A, 516<br /> Berthold Rzany</p>
<p>SECTION 6: Other important skin disorders<br /> Michael Bigby, editor</p>
<p>62 Cutaneous lupus erythematosus, 523<br /> Susan Jessop and David Whitelaw</p>
<p>63 Dermatomyositis, 531<br /> Ruth Ann Vleugels, David F. Fiorentino, and Jeffrey P. Callen</p>
<p>64 Acquired subepidermal bullous diseases, 545<br /> Gudula Kirtschig, Vanessa Venning, Nonhlanhla P. Khumalo, and Fenella Wojnarowska</p>
<p>65 Pemphigus, 552<br /> Linda K. Martin, Brian R. Sperber, Dedee F. Murrell, and Victoria P. Werth</p>
<p>66 Cutaneous sarcoidosis, 561<br /> Misha Rosenbach and Joseph C. English III</p>
<p>67 Erythema multiforme, 575<br /> Pierre–Dominique Ghislain and Jean–Claude Roujeau</p>
<p>68 Stevens Johnson syndrome and toxic epidermal necrolysis, 578<br /> Jean–Claude Roujeau, Pierre–Dominique Ghislain, and Laurence Valleyrie–Allanore</p>
<p>69 Polymorphic light eruption, 586<br /> Robert S. Dawe</p>
<p>70 Infantile hemangiomas, 590<br /> Hossain Shahidullah</p>
<p>71 Pruritus, 595<br /> Elke Weisshaar and Gil Yosipovitch</p>
<p>72 Vulval lichen sclerosus, erosive lichen planus, and vulvodynia, 615<br /> Rosalind C. Simpson, Ruth Murphy, and David Nunns</p>
<p>73 Venous ulcers, 624<br /> Jonathan Kantor, David J. Margolis, and Douglas J. Pugliese</p>
<p>74 Other skin diseases for which trials exist, 632<br /> Sinead Langan and Hywel C. Williams</p>
<p>PART IV: The future of evidence–based dermatology<br /> Luigi Naldi, editor</p>
<p>75 Where do we go from here?, 637<br /> Hywel C. Williams</p>
<p>Subject Index, 644</p>